Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare. The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry. Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.

Share:
More In Science
NASA's Mars Helicopter Takes Flight, 1st for Another Planet
NASA's experimental Mars helicopter has taken flight. The little 4-pound helicopter named Ingenuity rose into the thin air above the dusty red surface of Mars on Monday, achieving the first powered flight by an aircraft on another planet.
Why All New Apartment Buildings Look Identical
Developers and architects have been searching for creative solutions to zoning regulations. What started as a creative solution is now the standard blueprint for all modern apartment construction.
Load More